Medovir

Aciclovir, the active ingredient in Medovir, is an antiviral presented as an intravenous solution for IV use. It treats infections caused by herpes viruses, including herpes simplex, varicella‑zoster, and herpes encephalitis, in adult and pediatric patients as prescribed.

GNH USA supplies Medovir as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand. Customers benefit from reliable logistics, comprehensive documentation, and responsive technical support throughout the supply chain.

Aciclovir is an antiviral that targets herpesvirus infections.

Herpes simplex virus infections: reduces lesion formation and accelerates healing of oral and genital sores. Varicella‑zoster virus infections (shingles): alleviates pain and hastens rash resolution. Herpes encephalitis: limits viral replication in the central nervous system, improving survival outcomes.

Intravenous aciclovir may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Fever - Headache - Nausea

Serious or Rare Side Effects: - Acute renal failure - Seizures - Severe allergic reactions (anaphylaxis, Stevens‑Johnson syndrome)

When using Medovir, clinicians should observe several safety measures.

Renal function: assess baseline creatinine and adjust dose in impairment. Hydration: ensure adequate fluid intake to reduce nephrotoxicity risk. Concomitant nephrotoxic drugs: avoid or monitor when used with aminoglycosides, vancomycin, or NSAIDs. Hypersensitivity: discontinue if signs of allergic reaction appear. Pregnancy and lactation: use only if benefits outweigh potential risks, as safety data are limited. Store at room temperature: keep in original container, protect from moisture and light.

Aciclovir can interact with other medicines, requiring attention to avoid harmful effects.

Major Interactions (Avoid): - Probenecid: decreases renal clearance, increasing aciclovir plasma levels. - Cidofovir: additive nephrotoxicity when co‑administered. - Other nephrotoxic agents (e.g., aminoglycosides, vancomycin): heightened risk of renal injury.

Moderate Interactions (Monitor Closely): - NSAIDs: may impair renal function, requiring monitoring. - Loop diuretics: can exacerbate renal stress. - Warfarin: occasional alterations in INR, monitor coagulation.